Lymph-tone Ii

Aesculus Hipp, Azadirachta, Baryta Carb, Berber Vulg, Boldo, Bufo, Calc Carb, Calc Phos, Coenzyme A, Collinsonia, Echinacea, Ferrum Phos, Glandula Suprarenalis Suis, Hypothalamus, Kreosotum, Nadidum, Nat Mur, Phos, Phytolacca, Pinus Syl, Pituitarum Posterium, Pix Liquida, Pulsatilla, Silicea, Stillingia, Thuja Occ.

Energetix Corporation
Human Otc Drug
NDC 64578-0153

Lymph-tone Ii also known as Aesculus Hipp, Azadirachta, Baryta Carb, Berber Vulg, Boldo, Bufo, Calc Carb, Calc Phos, Coenzyme A, Collinsonia, Echinacea, Ferrum Phos, Glandula Suprarenalis Suis, Hypothalamus, Kreosotum, Nadidum, Nat Mur, Phos, Phytolacca, Pinus Syl, Pituitarum Posterium, Pix Liquida, Pulsatilla, Silicea, Stillingia, Thuja Occ. is a human otc drug labeled by 'Energetix Corporation'. National Drug Code (NDC) number for Lymph-tone Ii is 64578-0153. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Lymph-tone Ii drug includes Azadirachta Indica Bark - 8 [hp_X]/59.1mL Barium Carbonate - 12 [hp_X]/59.1mL Berberis Vulgaris Root Bark - 12 [hp_X]/59.1mL Bos Taurus Hypothalamus - 12 [hp_X]/59.1mL Bos Taurus Pituitary Gland - 12 [hp_X]/59.1mL Bufo Bufo Cutaneous Gland - 12 [hp_X]/59.1mL Coenzyme A - 12 [hp_X]/59.1mL Collinsonia Canadensis Root - 10 [hp_X]/59.1mL Echinacea Angustifolia - 6 [hp_X]/59.1mL Ferrum Phosphoricum - 12 [hp_X]/59.1mL and more. The currest status of Lymph-tone Ii drug is Active.

Drug Information:

Drug NDC:	64578-0153
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Lymph-tone Ii
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Aesculus Hipp, Azadirachta, Baryta Carb, Berber Vulg, Boldo, Bufo, Calc Carb, Calc Phos, Coenzyme A, Collinsonia, Echinacea, Ferrum Phos, Glandula Suprarenalis Suis, Hypothalamus, Kreosotum, Nadidum, Nat Mur, Phos, Phytolacca, Pinus Syl, Pituitarum Posterium, Pix Liquida, Pulsatilla, Silicea, Stillingia, Thuja Occ.
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Energetix Corporation
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	AZADIRACHTA INDICA BARK - 8 [hp_X]/59.1mL BARIUM CARBONATE - 12 [hp_X]/59.1mL BERBERIS VULGARIS ROOT BARK - 12 [hp_X]/59.1mL BOS TAURUS HYPOTHALAMUS - 12 [hp_X]/59.1mL BOS TAURUS PITUITARY GLAND - 12 [hp_X]/59.1mL BUFO BUFO CUTANEOUS GLAND - 12 [hp_X]/59.1mL COENZYME A - 12 [hp_X]/59.1mL COLLINSONIA CANADENSIS ROOT - 10 [hp_X]/59.1mL ECHINACEA ANGUSTIFOLIA - 6 [hp_X]/59.1mL FERRUM PHOSPHORICUM - 12 [hp_X]/59.1mL Load more... HORSE CHESTNUT - 12 [hp_X]/59.1mL NADIDE - 12 [hp_X]/59.1mL OYSTER SHELL CALCIUM CARBONATE, CRUDE - 12 [hp_X]/59.1mL PEUMUS BOLDUS LEAF - 4 [hp_X]/59.1mL PHOSPHORUS - 30 [hp_X]/59.1mL PHYTOLACCA AMERICANA ROOT - 4 [hp_X]/59.1mL PINE TAR - 6 [hp_X]/59.1mL PINUS SYLVESTRIS LEAFY TWIG - 9 [hp_X]/59.1mL PULSATILLA VULGARIS - 12 [hp_X]/59.1mL SILICON DIOXIDE - 12 [hp_X]/59.1mL SODIUM CHLORIDE - 12 [hp_X]/59.1mL STILLINGIA SYLVATICA ROOT - 4 [hp_X]/59.1mL SUS SCROFA ADRENAL GLAND - 9 [hp_X]/59.1mL THUJA OCCIDENTALIS LEAFY TWIG - 12 [hp_X]/59.1mL TRIBASIC CALCIUM PHOSPHATE - 12 [hp_X]/59.1mL WOOD CREOSOTE - 15 [hp_X]/59.1mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	03 Nov, 2017
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	13 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Energetix Corporation
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UNII:	G580B439YI 6P669D8HQ8 1TH8Q20J0U S6G2NLH4Y7 7JM57I419K Q59QU6N72Q SAA04E81UX O2630F3XDR VB06AV5US8 91GQH8I5F7 Load more... 3C18L6RJAZ 0U46U6E8UK 2E32821G6I Q4EWM09M3O 27YLU75U4W 11E6VI8VEG YFH4WC535J Q1RGP4UB73 I76KB35JEV ETJ7Z6XBU4 451W47IQ8X QBR70R4FBK 398IYQ16YV 1NT28V9397 91D9GV0Z28 3JYG22FD73
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class:	Blood Coagulation Factor [EPC] Calcium [CS] Cations Divalent [CS] Increased Coagulation Factor Activity [PE]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
64578-0153-1	59.1 mL in 1 BOTTLE, DROPPER (64578-0153-1)	03 Nov, 2017	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Lymph-tone Ii

Aesculus Hipp & more..

Liquid
Energetix Corporation
NDC: 64578-0153

Purpose:

âpurpose migrating pains, skin eruptions, fatigue, swollen glands.

Product Elements:

Lymph-tone ii aesculus hipp, azadirachta, baryta carb, berber vulg, boldo, bufo, calc carb, calc phos, coenzyme a, collinsonia, echinacea, ferrum phos, glandula suprarenalis suis, hypothalamus, kreosotum, nadidum, nat mur, phos, phytolacca, pinus syl, pituitarum posterium, pix liquida, pulsatilla, silicea, stillingia, thuja occ. horse chestnut horse chestnut azadirachta indica bark azadirachta indica bark barium carbonate barium cation berberis vulgaris root bark berberis vulgaris root bark peumus boldus leaf peumus boldus leaf bufo bufo cutaneous gland bufo bufo cutaneous gland oyster shell calcium carbonate, crude oyster shell calcium carbonate, crude tribasic calcium phosphate calcium cation coenzyme a coenzyme a collinsonia canadensis root collinsonia canadensis root echinacea angustifolia echinacea angustifolia ferrum phosphoricum ferrum phosphoricum sus scrofa adrenal gland sus scrofa adrenal gland bos taurus hypothalamus bos taurus hypothalamus wood creosote wood creosote nadide nadide sodium chloride chloride ion phosphorus phosphorus phytolacca americana root phytolacca americana root pinus sylvestris leafy twig pinus sylvestris leafy twig bos taurus pituitary gland bos taurus pituitary gland pine tar pine tar pulsatilla vulgaris pulsatilla vulgaris silicon dioxide silicon dioxide stillingia sylvatica root stillingia sylvatica root thuja occidentalis leafy twig thuja occidentalis leafy twig water alcohol glycerin

Indications and Usage:

Uses temporary relief of migrating pains, skin eruptions, fatigue, swollen glands.

Warnings:

Warnings in case of overdose, get medical help or contact a poison control center right away. if pregnant or breast feeding , ask a healthcare professional before use. keep out of reach of children.

Dosage and Administration:

Directions take 30 drops orally twice daily or as directed by a healthcare professional. consult a physician for use in children under 12 years of age or if symptoms worsen or persist.

Package Label Principal Display Panel:

EnergetixÂ® lymph-tone ii homeopathic remed y migrating pains, skin eruptions, fatigue, swollen glands. 2 fl oz (59.1 ml) / 15% ethyl alcohol âpurpose migrating pains, skin eruptions, fatigue, swollen glands. 2oz bottle label

Further Questions:

Distributed by energetix corp. dahlonega, ga 30533 questions? comments? 800.990.7085 www.goenergetix.com

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.